A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus (clinicaltrials.gov) - Sep 13, 2025 - P1 | N=12 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Aug 2025 ➔ Aug 2026 | Trial primary completion date: Aug 2025 ➔ May 2026
Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Infectious Disease
|